Dermatomyositis - key to diagnosing ovarian cancer, monitoring treatment and detecting recurrent disease: Case report
Authors:
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 23, 1-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Paraneoplastic Dermatomyositis with Cutaneous and Myopathic Disease Responsive to Adrenocorticotropic Hormone Therapy.2017
- Dermatomyositis as a paraneoplastic phenomenon in ovarian cancerBMJ Case Reports, 2016
- Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohortSeminars in Arthritis and Rheumatism, 2015
- Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgeryGynecologic Oncology Case Reports, 2013
- Perioperative Stress-Dose SteroidsClinics in Colon and Rectal Surgery, 2013
- Malignancy and myositis: novel autoantibodies and new insightsCurrent Opinion in Rheumatology, 2010
- Dermatomyositis as the Initial Presentation of Ovarian CancerTaiwanese Journal of Obstetrics and Gynecology, 2009
- Requirement of Perioperative Stress Doses of CorticosteroidsArchives of Surgery, 2008
- Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based studyThe Lancet, 2001
- Risk of Cancer in Patients with Dermatomyositis or PolymyositisNew England Journal of Medicine, 1992